Concepedia

Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment

Arzu R. Gürakar, Jeffrey M. Hoeg, Gerhard M. Kostner, Nicholas M. Papadopoulos, H. Bryan Brewer

Atherosclerosis · 1985 · 265 citations · 27 references

Concepts

Life SciencesBiochemistryPharmacologyChemotherapyLipid BiochemistryLipid DisordersLipid HomeostasisLipid MetabolismLipid Metabolism DisordersLipoprotein AnalysisLipoprotein MetabolismLipid Metabolism EffectsLipoprotein Metabolism RegulationLipoprotein(a) ElevationLipoprotein(a) Lowering TherapyVery Low-density Lipoprotein Metabolism

References

27

Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol.

G. Russell Warnick, J Benderson, J J Albers · Clinical Chemistry · 1982 · 2.2K citations

Life Sciences, Biochemistry, Analytical Chemistry +10

A NEW SERUM TYPE SYSTEM IN MAN—THE L<sub>p</sub> SYSTEM

Kåre Berg · Acta Pathologica Microbiologica Scandinavica · 1963 · 1.4K citations

Life Sciences, Biochemistry, Physiology +4

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

JAMA · 1984 · 780 citations

Medicine, Cardiology, Otolaryngology +11

Lipoprotein Lp(a) and the risk for myocardial infarction

Gerhard M. Kostner, P Avogaro, G. Cazzolato et al. · Atherosclerosis · 1981 · 691 citations

Medicine, Cardiology, Internal Medicine +14

Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.

John F. Brensike, R I Levy, S. F. Kelsey et al. · Circulation · 1984 · 680 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16